Table 2.
Associations between the genetic risk scores and cardiometabolic risk factors
| Variable | GRS-D
|
GRS-I
|
GRS-ALL
|
|||
|---|---|---|---|---|---|---|
| Beta (SE) | P | Beta (SE) | P | Beta (SE) | P | |
| BMI | 0.02 (0.05) | 0.74 | 0.24 (0.04) | 2.67×10−8 | 0.10 (0.03) | 6.14 ×10−5 |
| WHR | 0.0003 (0.001) | 0.68 | 0.002 (0.001) | 0.001 | 0.001 (0.0004) | 0.04 |
| Insulin | −1.37 (0.56) | 0.01 | 0.57 (0.51) | 0.26 | −0.19 (0.30) | 0.53 |
| Insulin* | −1.36 (0.48) | 0.005 | −0.77 (0.44) | 0.08 | −0.74 (0.26) | 0.005 |
| HOMA-IR | −0.05 (0.02) | 0.02 | 0.02 (0.02) | 0.26 | −0.01 (0.01) | 0.60 |
| HOMA-IR* | −0.05 (0.02) | 0.01 | −0.03 (0.02) | 0.08 | −0.03 (0.01) | 0.009 |
BMI=body mass index; GRS-ALL=genetic risk score including all 12 variants for body fat percentage; GRS-D=genetic risk score including three body fat percentage variants associated with decreased type 2 diabetes risk; GRS-I=genetic risk score including five body fat percentage variants associated with increased type 2 diabetes risk; HOMA-IR=homeostatic model assessment for of insulin resistance; WHR=waist-hip ratio
P values were adjusted for age, sex, smoking, and drinking.
additionally adjusted for body mass index.